SCRIPTGEN

pharmaceutical preparations for the treatment of infectious diseases including, but not limited to bacterial, fungal, and viral infections; peripheral or central nervous system diseases including, but not limited to schizophrenia, depression, alzheimers, migraines, anxiety, and pain; cardiovascular system diseases including, but not limited to atherosclerosis, hypertension, stroke, and congestive heart failure; digestive organs diseases including, but not limited to gastric ulcers, and esophagal reflux; musculosketal system diseases including, but not limited to arthritis; metabolic diseases including, but not limited to obesity and diabetes; respiratory system diseases including, but not limited to asthma, pneumonia, and tuberculosis; urogenital organs diseases including, but not limited to cystitis, yeast infections, and hepatitis; neoplastic diseases including, but not limited to cancer of the breast, lung, prostate, and colon; skin disorders including, but not limited to psoriasis and herpes; immune system diseases including, but not limited to HIV, rheumatoid arthritis, and immune suppression agents for organ transplants; hematopoietic diseases including, but not limited to sickle cell anemia, thalassemia, hemostasis and other blood disorders; genetic diseases including, but not limited to down's syndrome, Huntington's chorea, and cystic fibrosis; endocrine system diseases including, but not limited to symptoms of menopause; reproductive system diseases including, but not limited to fertility control

research services in the field of biology and medicine